The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Cohort profile: The Tromso Study
Open accessAbstract
The Tromsø Study was initiated in 1974 in an attempt to help combat the high mortality of cardiovascular diseases in Norway, that was particularly pronounced among middle-aged men. In the mid-1970s, Norwegian men had a 20% risk of dying of myocardial infarction (MI) before the age of 75 years. The situation in Northern Norway was even worse.1 The primary aim of the Tromsø Study was to determine causes of the high cardiovascular mortality, and also to develop ways of preventing heart attacks and strokes. This was reflected through the first name of the study: The Tromsø Heart Study. However, during the 37 years since the first examination of the Tromsø Study took place, increasing emphasis has been put on other chronic diseases and conditions, in particular atrial fibrillation, venous thromboembolism, diabetes mellitus, osteoporosis and fractures. It has been a deliberate policy to invite a wide range of faculty research groups to join in with subprojects in the surveys, and there are currently some 100 different ongoing research projects based on the data from the consecutive six surveys. The study was initially funded by the University of Tromsø, and has been so for the entire period since 1974, but there have also been substantial contributions, directly and indirectly from, for example, the National Screening Services, the Research Council of Norway, Northern Norway Regional Health Authority, Norwegian Council on Cardiovascular Diseases and Norwegian Foundation for Health and Rehabilitation. Teams of investigators approach public research programmes for funding of the different examinations conducted. Tromsø is the largest city in Northern Norway. It is situated ∼400 km north of the Arctic Circle, and has approximately 67 000 inhabitants. The physical living conditions are dominated by dramatic changes in the light with 2 months of midnight sun and 2 months of the polar night. However, due to the Gulf Stream, the climate is relatively mild, the latitude (69°N) taken into account. The Tromsø Study consists of six surveys (referred to as Tromsø 1–6) that have been conducted in the municipality of Tromsø from 1974 to 2008 (Table 1 and Figure 1). The Tromsø Study population includes subjects who have attended at least one of the six surveys, 40 051 subjects in total. As detailed below, the attendance rates have been high (>75% in surveys 1–5), but somewhat lower in the last survey (66%) conducted in 2007–08, due to lower attendance rate among the relatively young and those who never had participated in the previous Tromsø Study surveys. The Tromsø Study. Invitation by birth cohort and attained age in Tromsø 1–6. Invitation of total birth cohorts is marked as bold, shading indicates that samples of birth cohorts were invited. aAdjusted for deaths, emigration from Tromsø during the survey period etc. bMen only. c10% of total birth cohort and offspring of high-risk men who participated in a family intervention trial after the second survey. dRestricted to those who participated in the second visit in Tromsø 4. e 40% of the total birth cohorts. f10% of the total birth cohorts The Tromsø Studya aExamination year, age groups included and attendance rate. Number of subjects (n), mean age in the six different surveys according to gender and attendance. b20–49 years in women. cAll men aged 20–61 years and women aged 20–56 years were invited (see text). The Tromsø Studya aExamination year, age groups included and attendance rate. Number of subjects (n), mean age in the six different surveys according to gender and attendance. b20–49 years in women. cAll men aged 20–61 years and women aged 20–56 years were invited (see text). The six surveys had the same general design. Based on the official population registry, residents of the municipality of Tromsø were invited to take part in the survey. A personal invitation was mailed about 2 weeks before a suggested time of appointment. The subjects were free to attend whenever suitable within the time frame of the study (∼1 year). The invitation leaflet included information about the survey and the examination. Non-attendees were given one reminder. Tromsø 4–6 also included a second visit with a more extensive examination of the participants. Subjects in the population who were eligible for the second-visit examinations were identified before they were to attend the first visit of the survey. If they attended this, they were invited to the second-visit examination 2–4 weeks later. Table 1 gives the basic features of the Tromsø Study with regard to year of examination, the number of subjects who attended, age groups included and attendance rate. The table also gives the mean age according to gender and attendance in each of the six surveys. The aim has been to include large, representative samples of the Tromsø population, with invitation of whole birth cohorts and random samples. We have obtained repeated measurement from the same population. Figure 1 shows the general outline
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,204
Larsen, I. K., Småstuen, M., Johannesen, T. B., Langmark, F., Parkin, D. M., Bray, F., & Møller, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.037 · Cited by 848
NILSSEN, O., FØRDE, O. H., & BRENN, T. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115661 · Cited by 815
Serum Total Homocysteine and Coronary Heart Disease
ARNESEN, E., REFSUM, H., BØNAA, K. H., UELAND, P. M., FØRDE, O. H., & NORDREHAUG, J. E. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.4.704 · Cited by 651
Singh, K. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.3.236 · Cited by 634
Eriksen, B. O., & Ingebretsen, O. C. (2006) · Kidney International · doi:10.1038/sj.ki.5000058 · Cited by 576
Mathiesen, E. B., Bønaa, K. H., & Joakimsen, O. (2001) · Circulation · doi:10.1161/01.cir.103.17.2171 · Cited by 573
Self-citationThe Tromsø Heart Study: Does Coffee Raise Serum Cholesterol?
Thelle, D. S., Arnesen, E., & Førde, O. H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082405 · Cited by 491
A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke
Gudbjartsson, D. F., Holm, H., Gretarsdottir, S., Thorleifsson, G., Walters, G. B., Thorgeirsson, G., Gulcher, J., Mathiesen, E. B., Njølstad, I., Nyrnes, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.417 · Cited by 489
Self-citationde Weerd, M., Greving, J. P., Hedblad, B., Lorenz, M. W., Mathiesen, E. B., O'Leary, D. H., Rosvall, M., Sitzer, M., Buskens, E., & Bots, M. L. (2010) · Stroke · doi:10.1161/strokeaha.110.581058 · Cited by 435
Self-citationBønaa, K. H., Bjerve, K. S., Straume, B., Gram, I. T., & Thelle, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221202 · Cited by 413
Johnsen, S. H., Mathiesen, E. B., Joakimsen, O., Stensland, E., Wilsgaard, T., Løchen, M.-L., Njølstad, I., & Arnesen, E. (2007) · Stroke · doi:10.1161/strokeaha.107.487264 · Cited by 398
Self-citationGran, J. T., Husby, G., & Hordvik, M. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.6.359 · Cited by 235
RISK FACTORS FOR CORONARY HEART DISEASE AND LEVEL OF EDUCATION
JACOBSEN, B. K., & THELLE, D. S. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114895 · Cited by 208
Self-citationCohort Profile: Cohort of Norway (CONOR)
Naess, O., Sogaard, A. J., Arnesen, E., Beckstrom, A. C., Bjertness, E., Engeland, A., Hjort, P. F., Holmen, J., Magnus, P., Njolstad, I., et al. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym217 · Cited by 206
Self-citationThe Emerging Risk Factors Collaboration (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9165-7 · Cited by 188
Association of Albuminuria and Cancer Incidence
Jørgensen, L., Heuch, I., Jenssen, T., & Jacobsen, B. K. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060712 · Cited by 160
Self-citationThe Tromsø Heart Study: Methods and Main Results of the Cross‐sectional Study
Thelle, D. S., Førde, O. H., Try, K., & Lehmann, E. H. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08204.x · Cited by 159
ISHIKAWA, T., Fidge, N., Thelle, D. S., Førde, O. H., & Miller, N. E. (1978) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1978.tb00832.x · Cited by 126
Knutsen, S., & Knutsen, R. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90020-5 · Cited by 103
Increase in Weight in All Birth Cohorts in a General Population
Jacobsen, B. K., Njølstad, I., Thune, I., Wilsgaard, T., Løchen, M., & Schirmer, H. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.466 · Cited by 85
Self-citationThe Tromsø Heart Study: Responders and Non-responders to a Health Questionnaire, Do They Differ?
Jacobsen, B. K., & Thelle, D. S. (1988) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488801600207 · Cited by 81
Self-citationCoffee and cholesterol: is it all in the brewing? The Tromsø Study.
Bønaa, K. H., Arnesen, E., Thelle, D. S., & Førde, O. H. (1988) · BMJ · doi:10.1136/bmj.297.6656.1103 · Cited by 68
Weight loss and mortality: A gender-specific analysis of the Tromsø study
Wilsgaard, T., Jacobsen, B. K., Mathiesen, E. B., & Njølstad, I. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.12.003 · Cited by 17
Self-citationJørgensen, L., Jenssen, T. G., Heuch, I., & Jacobsen, B. K. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01992.x · Cited by 13
Self-citation
Cited by
Vitamin D deficiency in Europe: pandemic?
Cashman, K. D., Dowling, K. G., Škrabáková, Z., Gonzalez-Gross, M., Valtueña, J., De Henauw, S., Moreno, L., Damsgaard, C. T., Michaelsen, K. F., Mølgaard, C., et al. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.120873 · Cited by 1,393
The evolving epidemiology of valvular aortic stenosis. The Tromsø Study
Eveborn, G. W., Schirmer, H., Heggelund, G., Lunde, P., & Rasmussen, K. (2013) · Heart · doi:10.1136/heartjnl-2012-302265 · Cited by 648
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Voight, B. F., Kang, H. M., Ding, J., Palmer, C. D., Sidore, C., Chines, P. S., Burtt, N. P., Fuchsberger, C., Li, Y., Erdmann, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002793 · Cited by 472
Langhammer, A., Krokstad, S., Romundstad, P., Heggland, J., & Holmen, J. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-143 · Cited by 388
Metadata
- Authors
- Jacobsen, B. K., Eggen, A. E., Mathiesen, E. B., Wilsgaard, T., & Njolstad, I.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-21
- Volume
- 41
- Issue
- 4
- Pages
- 961-967
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2133304451
- Cited by
- 694
- References
- 26
- FWCI
- 28.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.